The adrenomimetic dobutamine stimulates proliferative activity of hepatocytes and suppresses fibroblasts in mice with posttoxic experimental cirrhosis.
Gorbenko
A S
AS
Institute of Biophysics, Siberian Division, Russian Academy of Sciences, Akademgorodok, Krasnoyarsk 36, Russia.
Setkov
N A
NA
D000322:Adrenergic Agonists / Q000494:pharmacology*; D000818:Animals; D002251:Carbon Tetrachloride / Q000494:pharmacology; D002455:Cell Division; D004280:Dobutamine / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005260:Female; D005347:Fibroblasts / Q000378:metabolism*; D022781:Hepatocytes / Q000378:metabolism* / Q000473:pathology*; D007700:Kinetics; D008099:Liver / Q000378:metabolism; D008106:Liver Cirrhosis, Experimental / Q000139:chemically induced / Q000378:metabolism*; D051379:Mice; D008807:Mice, Inbred BALB C; D013997:Time Factors
D000322:Adrenergic Agonists; D004280:Dobutamine; D002251:Carbon Tetrachloride